A dependable Indian source for hospital pharmacy and hospital-group formulary lines
M Care Exports is a CDSCO-licensed merchant exporter based in Mumbai since 2002, supplying hospital pharmacies, private and public hospital groups, and their appointed importers and distributors across 49 export markets. We are a manufacturer-side partner, not a manufacturer: we source WHO-GMP finished-dose medicines, hold the documentation your formulary committee needs, and dispatch against rate contracts and framework calls. If you are a tertiary hospital, a day-care oncology unit, or a distributor needing a steady Indian line, we are built for that.
What we supply into hospital pharmacies
Hospital demand is different from retail. Wards, theatres, intensive care, and day units draw most of their volume from sterile injectables and controlled-temperature lines, not blister packs. We source against the inpatient basket your formulary actually runs on, and we keep the documentation trail that a hospital pharmacy and its importer need at goods-in and at audit. Below is the shape of what we handle.
Injectables and parenteral lines
Small-volume injectables and large-volume parenterals carry a disproportionate share of inpatient volume and of global shortages. We source WHO-GMP sterile lines: IV antibiotics, anaesthesia and ICU agents, electrolytes, and infusion solutions, sourced to the strengths, fill volumes, and pack presentations your formulary specifies.
Oncology cytotoxics for day units
Cytotoxic and high-potency injectables sit at the centre of day-care oncology and are among the most shortage-prone categories. We source these as finished doses from WHO-GMP facilities with the batch documentation a hospital pharmacy needs for preparation and reconstitution under its own aseptic controls.
Cold-chain and controlled-temperature stock
Lines that must hold 2 to 8 degrees Celsius travel under Good Distribution Practice with continuous temperature monitoring, qualified packaging, and a recorded audit trail across the route. We coordinate the controlled-temperature leg with your importer so excursions are visible and documented before goods-in.
When hospital buyers come to us
A formulary line that needs a second source
A hospital group or its distributor wants a reliable Indian source for a specific formulary molecule, often because the incumbent has gone short or the price has drifted. We quote the WHO-GMP line, supply the documentation pack for the therapeutics committee, and set up repeat dispatch against a rate contract.
A standing oncology day-unit basket
An oncology day unit needs predictable supply of cytotoxic injectables across a course of treatment, not a single order. We source the basket, agree call-off quantities, and hold the dossier and batch paperwork your pharmacy and importer need at each delivery.
An ICU and anaesthesia basket
Intensive care and theatre run on a tight cluster of injectable agents where a gap is clinically serious. We quote the whole ICU and anaesthesia basket as one line, source it WHO-GMP, and structure deliveries so the unit holds working stock without overstocking short-dated lines.
A shortage backfill on a critical medicine
When a critical hospital medicine goes short and the usual supplier cannot deliver, we step in as the manufacturer-side backfill. We confirm availability against WHO-GMP stock, agree quantities with your importer, and move the line on a compressed timeline to cover the gap.
How the import and documentation actually work
The single most common question from a hospital buyer is who holds the import licence. The answer shapes everything else. We are the India-side supplier; a licensed party in your market is the importer of record. Here is how that split works and what each side carries.
Who is the importer of record
M Care is manufacturer-side in India. The import licence and the destination marketing authorisation are held by a licensed local importer or distributor, or by the hospital group itself where it holds that authorisation. We supply into that licensed channel; we do not act as the importer in your market.
What we provide from India
We are a CDSCO-licensed exporter. We arrange the export documentation that hospital registration and customs clearance rely on, including the Certificate of Pharmaceutical Product and WHO-GMP evidence for the source facility, alongside batch and quality paperwork for each consignment.
Serialisation and track-and-trace
Regulated markets require pack-level serialisation. In the EU, in-scope packs carry a 2D Data Matrix unique identifier and an anti-tamper feature under the Falsified Medicines Directive. We source packs prepared to the destination scheme so your importer can commission and verify codes.
Cold-chain under GDP
Controlled-temperature lines move under Good Distribution Practice. We coordinate qualified packaging, continuous monitoring, and the temperature record for the India-side leg, and we hand a clean audit trail to your importer for the onward controlled-temperature journey.
Labelling in the destination language
Packs are sourced to the destination labelling rules. Gulf markets generally require Arabic and English; other markets require their own national language. We confirm the labelling and leaflet language with your importer before a line is committed so goods-in is not held.
Continuity and shortage cover
Critical hospital lines need supply that does not break. We structure rate contracts with agreed call-off quantities and buffer cover so a formulary line keeps running across quarters, and we hold the same source on file for shortage backfill when an incumbent fails.
From enquiry to supply, step by step.
- Share the formulary line or basket. Send us the molecule, strength, dosage form, pack presentation, and indicative annual quantity, whether that is a single formulary line, an oncology day-unit basket, or an ICU and anaesthesia cluster. Tell us the destination market and who will act as importer of record.
- We source and quote WHO-GMP. We match the requirement to WHO-GMP finished-dose sources, confirm availability and lead time, and return a quotation with the source facility's compliance status, pack and labelling details, and any serialisation or cold-chain handling the destination requires.
- Documentation for your committee. We supply the documentation pack your formulary and therapeutics committee and your importer need: Certificate of Pharmaceutical Product, WHO-GMP evidence, and batch and quality paperwork. Your importer confirms the destination registration and import authorisation.
- Agree the contract and call-off. We set up a rate contract or framework supply arrangement with agreed call-off quantities and a delivery schedule, including buffer cover for critical lines, so the hospital holds working stock without carrying short-dated risk.
- Dispatch, monitor, and resupply. We dispatch each consignment with full paperwork, coordinate cold-chain monitoring where it applies, and keep the line on standing resupply. If a shortage hits the wider market, the same source is already on file for a fast backfill.
The specifics.
Are you a manufacturer of these hospital medicines?
No. M Care Exports is an India-based pharmaceutical merchant exporter and manufacturer-side partner. We source finished-dose medicines from WHO-GMP facilities and supply them to hospital pharmacies, hospital groups, and their importers. We do not own manufacturing. This matters at audit: we are transparent that the quality status belongs to the source facility, and we supply the documentation that proves it.
Who holds the import licence, you or the hospital?
A licensed party in your market does. That is usually a local importer or distributor, or the hospital group where it holds the import authorisation and the destination marketing authorisation. We are the India-side supplier into that licensed channel. We do not act as the importer of record in your market, and we will tell you early if a line needs an importer you do not yet have appointed.
How is this different from your government tender service?
Our government supply service responds to national tenders run by central medical-stores authorities and health ministries. This service is the hospital and private channel: individual hospital pharmacies, public and private hospital groups, group purchasing organisations, and their distributors, buying against formularies, rate contracts, and framework calls rather than a national tender. Many buyers use both, but the procurement route and documentation rhythm differ.
Can you supply oncology cytotoxic injectables to a day unit?
Yes. We source cytotoxic and high-potency injectables as finished doses from WHO-GMP facilities, with the batch documentation your pharmacy needs. Preparation, reconstitution, and aseptic compounding remain with the hospital under its own controls and licences. We supply the product and the paperwork; we do not compound or prepare doses, and we do not provide clinical advice on administration.
How do you handle cold-chain hospital lines?
Controlled-temperature lines move under Good Distribution Practice. Products that must hold 2 to 8 degrees Celsius travel in qualified packaging with continuous temperature monitoring and a recorded audit trail. We manage and document the India-side leg and hand a clean temperature record to your importer, who carries the onward controlled-temperature journey to the hospital.
What about serialisation and track-and-trace?
Regulated markets require pack-level serialisation. Under the EU Falsified Medicines Directive, in-scope packs carry a unique identifier in a 2D Data Matrix code plus an anti-tamper feature, and hospital dispensing involves verification and decommissioning of the code. We source packs prepared to the destination scheme so your importer can commission, verify, and decommission codes as the local system requires.
Can you backfill a shortage on a critical medicine?
Yes. Sterile injectables and oncology lines are the categories most prone to shortage, and a backfill is one of the most common reasons hospitals approach us. We confirm availability against WHO-GMP stock, agree quantities with your importer, and move the line on a compressed timeline. We are honest about lead times: a genuine backfill still depends on source availability and destination clearance.
Do packs come labelled in our language?
Yes. We source packs and leaflets to the destination labelling rules. Gulf markets generally require Arabic and English; other markets require their own national language. We confirm the exact labelling and leaflet language with your importer before a line is committed, so the consignment is not held at goods-in for a labelling discrepancy.
Tell us the formulary line you need covered
Send us the molecule, dosage form, pack, and destination market, plus who will act as your importer of record. We will come back with WHO-GMP availability, the documentation your committee needs, and a supply arrangement that keeps the line running. Whether it is a single formulary item, an oncology day-unit basket, an ICU and anaesthesia cluster, or a shortage backfill, we will tell you plainly what we can source and how fast.